KalVista Pharmaceuticals Statistics
Total Valuation
KALV has a market cap or net worth of $1.43 billion. The enterprise value is $1.43 billion.
Important Dates
The last earnings date was Thursday, May 14, 2026, after market close.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KALV has 53.24 million shares outstanding. The number of shares has increased by 9.26% in one year.
| Current Share Class | 53.24M |
| Shares Outstanding | 53.24M |
| Shares Change (YoY) | +9.26% |
| Shares Change (QoQ) | -1.09% |
| Owned by Insiders (%) | 1.71% |
| Owned by Institutions (%) | 106.50% |
| Float | 38.21M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 12.46 |
| Forward PS | 8.36 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 12.45 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.17
| Current Ratio | 5.17 |
| Quick Ratio | 4.97 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.37 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -52.22% |
| Weighted Average Cost of Capital (WACC) | 4.00% |
| Revenue Per Employee | $416,291 |
| Profits Per Employee | -$494,316 |
| Employee Count | 275 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -5.80M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +125.70% in the last 52 weeks. The beta is -0.12, so KALV's price volatility has been lower than the market average.
| Beta (5Y) | -0.12 |
| 52-Week Price Change | +125.70% |
| 50-Day Moving Average | 21.67 |
| 200-Day Moving Average | 16.00 |
| Relative Strength Index (RSI) | 74.65 |
| Average Volume (20 Days) | 7,464,520 |
Short Selling Information
The latest short interest is 15.16 million, so 28.48% of the outstanding shares have been sold short.
| Short Interest | 15.16M |
| Short Previous Month | 19.65M |
| Short % of Shares Out | 28.48% |
| Short % of Float | 39.68% |
| Short Ratio (days to cover) | 3.21 |
Income Statement
In the last 12 months, KALV had revenue of $114.48 million and -$135.94 million in losses. Loss per share was -$2.51.
| Revenue | 114.48M |
| Gross Profit | 58.47M |
| Operating Income | -140.00M |
| Pretax Income | -141.73M |
| Net Income | -135.94M |
| EBITDA | -138.45M |
| EBIT | -140.00M |
| Loss Per Share | -$2.51 |
Full Income StatementBalance Sheet
The company has $285.03 million in cash and $284.31 million in debt, with a net cash position of $718,000 or $0.01 per share.
| Cash & Cash Equivalents | 285.03M |
| Total Debt | 284.31M |
| Net Cash | 718,000 |
| Net Cash Per Share | $0.01 |
| Equity (Book Value) | -19.65M |
| Book Value Per Share | -0.38 |
| Working Capital | 253.39M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$89.32 million and capital expenditures -$2.39 million, giving a free cash flow of -$91.71 million.
| Operating Cash Flow | -89.32M |
| Capital Expenditures | -2.39M |
| Depreciation & Amortization | 1.56M |
| Net Borrowing | 208.57M |
| Free Cash Flow | -91.71M |
| FCF Per Share | -$1.72 |
Full Cash Flow StatementMargins
Gross margin is 51.07%, with operating and profit margins of -122.30% and -118.74%.
| Gross Margin | 51.07% |
| Operating Margin | -122.30% |
| Pretax Margin | -123.81% |
| Profit Margin | -118.74% |
| EBITDA Margin | -120.94% |
| EBIT Margin | -122.30% |
| FCF Margin | n/a |
Dividends & Yields
KALV does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.26% |
| Shareholder Yield | -9.26% |
| Earnings Yield | -9.53% |
| FCF Yield | -6.43% |
Analyst Forecast
The average price target for KALV is $28.60, which is 6.76% higher than the current price. The consensus rating is "Hold".
| Price Target | $28.60 |
| Price Target Difference | 6.76% |
| Analyst Consensus | Hold |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 33.98% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KALV has an Altman Z-Score of -2.28 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.28 |
| Piotroski F-Score | 1 |
